Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 836-845

  McGill Jr , Henry C ^b   McMahan, C Alex ^c   Herderick, Edward E ^c   Tracy, Richard E ^a   Malcom, Gray T ^a   Zieske, Arthur W ^a   Strong, Jack P ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c Louisiana Stt Univ Medical Center ^*

Author keywords

Aorta; Atherosclerosis; Coronary artery; Risk factors; Topography

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGE; AORTA ATHEROSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; ORGAN DISTRIBUTION; PRIORITY JOURNAL; RACE DIFFERENCE; RIGHT CORONARY ARTERY; RISK ASSESSMENT;

EID: 0342980340     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.836     Document Type: Article

References (39)

1. Fry DL. Acute vascular endothelial changes associated with increased blood velocity gradients. Circ Res. 1968;22:165-197.
2. Friedman MH. A biologically plausible model of thickening of arterial intima under shear. Arteriosclerosis. 1989;9:511-522.
3. Nerem RM. Vascular fluid mechanics, the arterial wall, and atherosclerosis. J Biomed Eng. 1992;114:274-282.
4. Giddens DP, Zarins CK, Glagov S. The role of fluid mechanics in the localization and detection of atherosclerosis. J Biomed Eng. 1993;115: 588-594.
5. Ross R. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis. 1981;1: 293-311.
6. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973;70:1753-1756.
7. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A. 1983;80:6386-6389.
8. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis. 1983;3:187-198.
9. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP, Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15:431-440.
10. McGill HC Jr, McMahan CA, Tracy RE, Oalmann MC, Cornhill JF, Herderick EE, Strong JP, for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Arterioscler Thromb Vasc Biol. 1998;18: 1108-1118.
11. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP, for the PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17:95-106.
12. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis. 1976;23:451-476.
13. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462-2478.
14. Stehbens WE. The epidemiological relationship of hypercholesterolemia, hypertension, diabetes mellitus and obesity to coronary heart disease and atherogenesis. J Clin Epidemiol. 1990;43:733-741.
15. Tejada C, Strong JP, Montenegro MR, Restrepo C, Solberg LA. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 1968;18:509-526.
16. Cornhill JF, Herderick EE, Vince DG, PDAY Research Group. The clinical morphology of human atherosclerotic lesions: lessons from the PDAY Study. Wien Klin Wochenschr. 1995;107:540-543.
17. Wissler RW. U S A Multicenter Study of the pathobiology of atherosclerosis in youth. Ann N Y Acad Sci. 1991;623:26-39.
18. Guzman MA, McMahan CA, McGill HC Jr, Strong JP, Tejada C, Restrepo C, Eggen DA, Robertson WB, Solberg LA. Selected methodologic aspects of the International Atherosclerosis Project. Lab Invest. 1968;18:479-497.
19. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
20. Glanville JN. Post-mortem serum cholesterol levels. BMJ. 1960;2: 1852-1853.
21. Hornick CA, Baker HN, Malcom GT, Newman WP, Roheim PS, Strong JP. Lipoproteins and apolipoproteins in postmortem serum. Mod Pathol. 1988;1:480-484.
22. Bowler RG. The determination of thiocyanate in blood serum. Biochem J. 1944;38:385-388.
23. Klenk DC, Hermanson GT, Krohn RI, Fujimoto EK, Mallia AK, Smith PK, England JD, Wiedemeyer H-M, Little RR, Goldstein DE. Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem. 1982;28:2088-2094.
24. Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes. 1993;42:1549-1554.
25. Tracy RE, Berenson G, Wattigney W, Barrett TJ. The evolution of benign arterionephrosclerosis from age 6 to 70 years. Am J Pathol. 1990;136: 429-439.
26. McGill HC Jr, Strong JP, Tracy RE, McMahan CA, Oalmann MC, Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of a postmortem renal index of hypertension to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15: 2222-2228.
27. Morrison DF. Multivariate Statistical Methods. New York, NY: McGraw-Hill; 1967.
28. Carroll RJ, Ruppert D. Transformation and Weighting in Regression. New York, NY: Chapman and Hall; 1988.
29. Montenegro MR, Eggen DA. Topography of atherosclerosis in the coronary arteries. Lab Invest. 1968;18:586-593.
30. Hata Y, Hower J, Insull W Jr. Cholesteryl ester-rich inclusions from human aortic fatty streak and fibrous plaque lesions of atherosclerosis, I: crystalline properties; size and internal structure. Am J Pathol. 1974;75: 423-456.
31. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions: demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest. 1976;58: 200-211.
32. Bocan TMA, Guyton JR. Human aortic fibrolipid lesions: progenitor lesions for fibrous plaques, exhibiting early formation of the cholesterolrich core. Am J Pathol. 1985;120:193-206.
33. Bocan TMA, Schifani TA, Guyton JR. Ultrastructure of the human aortic fibrolipid lesion: formation of the atherosclerotic lipid-rich core. Am J Pathol. 1986;123:413-424.
34. Guyton JR, Klemp KF. Transitional features in human atherosclerosis: intimai thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am J Pathol. 1993;143:1444-1457.
35. Guyton JR, Klemp KF. Development of the atherosclerotic core region: chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler Thromb. 1994;14:1305-1314.
36. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl 1):I-19-I-32.
37. Friedman MH, Brinkman AM, Qin JJ, Seed WA. Relation between coronary artery geometry and the distribution of early sudanophilic lesions. Atherosclerosis. 1993;98:193-199.
38. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
39. Auerbach O, Garfinkel L. Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest. 1980;78:805-809.